Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey)
Senegal introduced the infant hepatitis B virus (HBV) vaccination in 2004 and recently committed to eliminating hepatitis B by 2030. Updated epidemiological data are needed to provide information on the progress being made and to develop new interventions. We estimated the prevalence of hepatitis B...
Main Authors: | Lauren Périères, Aldiouma Diallo, Fabienne Marcellin, Marie Libérée Nishimwe, El Hadji Ba, Marion Coste, Gora Lo, Philippe Halfon, Coumba Touré Kane, Gwenaëlle Maradan, Patrizia Carrieri, Assane Diouf, Yusuke Shimakawa, Cheikh Sokhna, Sylvie Boyer, ANRS 12356 AmBASS Survey Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-05-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1879 |
Similar Items
-
Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey)
by: Tchadine Djaogol, et al.
Published: (2023-05-01) -
Hepatitis B Vaccination in Senegalese Children: Coverage, Timeliness, and Sociodemographic Determinants of Non-Adherence to Immunisation Schedules (ANRS 12356 AmBASS Survey)
by: Lauren Périères, et al.
Published: (2021-05-01) -
The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study)
by: Andréa Gosset, et al.
Published: (2021-05-01) -
Pain in methadone patients: Time to address undertreatment and suicide risk (ANRS-Methaville trial).
by: Sandra Nordmann, et al.
Published: (2017-01-01) -
Prevention and care of hepatitis B in the rural region of Fatick in Senegal: a healthcare workers’ perspective using a mixed methods approach
by: Tchadine Djaogol, et al.
Published: (2019-09-01)